We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$81B
AUM Growth
+$1.17B
(+1.5%)
Cap. Flow
-$2.37B
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
26.64%
Holding
1,562
New
88
Increased
546
Reduced
606
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$258M |
| 2 |
Brookfield Asset Management
BAM
|
+$211M |
| 3 |
Atlassian
TEAM
|
+$197M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$190M |
| 5 |
Progressive
PGR
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$396M |
| 2 |
Tesla
TSLA
|
+$335M |
| 3 |
Amazon
AMZN
|
+$310M |
| 4 |
Brookfield
BN
|
+$284M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.44% |
| 2 | Technology | 17.09% |
| 3 | Healthcare | 11.75% |
| 4 | Industrials | 8.45% |
| 5 | Energy | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CWAN
1251
DELISTED
Clearwater Analytics
CWAN
| $590K | ﹤0.01% |
31,460
| – | – |
|
|
KYNB
1252
Kyntra Bio
KYNB
$27.4M
| $588K | ﹤0.01% |
+1,468
| New | +$562K |
|
1253
UGI
UGI
$7.78B
| $586K | ﹤0.01% |
15,810
+100
| +0.6% | +$3.61K |
|
1254
S&T Bancorp
STBA
$1.85B
| $584K | ﹤0.01% |
17,100
-12,700
| -43% | -$445K |
|
1255
Woodside Energy
WDS
$43.1B
| $584K | ﹤0.01% |
24,139
-660
| -3% | -$15.7K |
|
1256
Banner Corp
BANR
$2.4B
| $581K | ﹤0.01% |
9,200
| – | – |
|
1257
Resideo Technologies
REZI
$5.49B
| $579K | ﹤0.01% |
+35,200
| New | +$638K |
|
1258
Upwork
UPWK
$1.18B
| $578K | ﹤0.01% |
55,380
| – | – |
|
|
BLFY
1259
DELISTED
Blue Foundry Bancorp
BLFY
| $574K | ﹤0.01% |
44,650
| – | – |
|
1260
Central Pacific Financial
CPF
$1.02B
| $572K | ﹤0.01% |
28,200
| – | – |
|
1261
Pliant Therapeutics
PLRX
$64.4M
| $571K | ﹤0.01% |
29,560
| – | – |
|
1262
HEICO Corp Class A
HEI.A
$36.6B
| $571K | ﹤0.01% |
4,762
+190
| +4% | +$23.2K |
|
1263
Pennant Group
PNTG
$1.4B
| $567K | ﹤0.01% |
51,654
+10,018
| +24% | +$109K |
|
1264
Ally Financial
ALLY
$13.4B
| $567K | ﹤0.01% |
23,190
-243,541
| -91% | -$6.48M |
|
1265
Aura Biosciences
AURA
$728M
| $567K | ﹤0.01% |
+53,956
| New | +$687K |
|
1266
Floor & Decor
FND
$6.08B
| $563K | ﹤0.01% |
8,081
+652
| +9% | +$47.4K |
|
1267
Vale
VALE
$62B
| $560K | ﹤0.01% |
33,023
-1,165
| -3% | -$17.5K |
|
1268
Fulgent Genetics
FLGT
$500M
| $560K | ﹤0.01% |
18,800
+2,300
| +14% | +$82.3K |
|
|
IGMS
1269
DELISTED
IGM Biosciences
IGMS
| $554K | ﹤0.01% |
32,559
| – | – |
|
1270
LCI Industries
LCII
$2.52B
| $545K | ﹤0.01% |
5,890
-1,123
| -16% | -$110K |
|
1271
Kura Oncology
KURA
$816M
| $544K | ﹤0.01% |
43,840
+3,800
| +9% | +$55.2K |
|
1272
Helmerich & Payne
HP
$3.41B
| $540K | ﹤0.01% |
+10,900
| New | +$519K |
|
1273
Erie Indemnity
ERIE
$12.4B
| $536K | ﹤0.01% |
2,155
+150
| +7% | +$38.6K |
|
1274
Hain Celestial
HAIN
$45.5M
| $533K | ﹤0.01% |
32,967
-2,613
| -7% | -$46.6K |
|
|
THRX
1275
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $533K | ﹤0.01% |
106,948
| – | – |
|
Similar funds
VAM
TD Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, TD Asset Management held 1,562 positions worth $81B, up 1.5% from $79.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management's Q4 2022 filing shows 88 new, 546 increased, 606 reduced and 117 closed positions. Its largest new stake was Brookfield Asset Management: 7,008,054 shares worth $201M. The largest sale was Alphabet (Google) Class C, an estimated $396M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
- TD Asset Management's largest Q4 2022 buy was Brookfield Asset Management: 7,008,054 shares worth $201M.
- TD Asset Management added most to iShares MSCI Japan ETF in Q4 2022, an estimated $258M increase.
- TD Asset Management's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $396M.
- TD Asset Management fully exited Corcept Therapeutics in Q4 2022, selling an estimated $25.4M.
- TD Asset Management's ten largest holdings make up 27% of its $81B portfolio in Q4 2022.
- TD Asset Management opened 88 new positions and closed 117 in Q4 2022.
- TD Asset Management's portfolio value rose 1.5% quarter-over-quarter to $81B.
Based on TD Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.